Our Latest Review on Targeting Mutant p53 Is Now Published
- MedOrg Group

- há 3 dias
- 1 min de leitura
We are pleased to announce the publication of our latest review article, "Drugging p53 mutants: Recent advances using small-molecule modulation strategies," in the European Journal of Medicinal Chemistry.
This review provides a comprehensive overview of the latest advances in targeting mutant p53 proteins through small-molecule modulation strategies. It explores the molecular mechanisms underlying these approaches, highlights key developments that have shaped the field, and discusses emerging opportunities for the development of more effective therapies targeting mutant p53.
This publication reflects the collaborative efforts of our team and the valuable contributions of our researchers, including Maria M. M. Santos and Tomás G. Monteiro in a colaborations with a previous member of our group Elizabeth A. Lopes.
If you're interested in mutant p53 biology, medicinal chemistry, and innovative therapeutic strategies for cancer, we invite you to read our review here: https://www.sciencedirect.com/science/article/pii/S0223523426005945





Comentários